Larvol Delta - BioPath-Holdings-Successfully-Completes-First-Dose-Cohort-of-Phase-11b-Clinical-Trial-of-BP1002-in-RefractoryRelapsed-Acute-Myeloid-Leukemia

liposomal Bcl2 (BP1002) - Bio-Path

https://www.globenewswire.com/news-release/2023/12/14/2796128/0/en/Bio-Path-Holdings-Successfully-Completes-First-Dose-Cohort-of-Phase-1-1b-Clinical-Trial-of-BP1002-in-Refractory-Relapsed-Acute-Myeloid-Leukemia.html

Dec 14, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next